doi:10.1016/j.tiv.2012.01.020 11.Sugimoto T, Nishida N, Yasuhara A, Ono A, Sakane Y, Matsumura T
150 mcg
Thats exactly who should be getting this therapy. Targeting Alstrm Syndrome In Effectiveness of the Dual GIP/GLP1-Agonist Tirzepatide in 2 Cases of Alstrm Syndrome, a Rare Obesity Syndrome , published in JCEM in April, Thomas Scherer, MD, of the Medical University of Vienna, in Vienna, Austria, and team showed tirzepatides efficacy even in the particularly difficult-to-treat Alstrm syndrome (AS), a rare, genetic, multisystemic disorder, characterized by, among other conditions, diabetes with profound insulin resistance due to marked hyperphagia
2024 Feb 5;7(2):e1864
Why Therapy is Important to Autism Care Unlike many medical conditions, autism does not have a pharmaceutical cure
In older adults, this translates to improved ease in tasks like standing, walking, and lifting everyday objectsfunctional markers often impacted by age-related muscle decline